Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,972 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nurse and allied health professional experiences and attitudes toward critical care research: A national questionnaire study.
Battle C, Lynch C, Discroll T, Thorpe C, Hatchley B, Biggs S, Phillips R, Roberts A, Roberts S, Cole J, Davies R, Hobrok M, Canning D, Littler C, Williams A, Pugh R. Battle C, et al. Among authors: roberts s, roberts a. J Intensive Care Soc. 2022 Feb;23(1):2-10. doi: 10.1177/1751143720968659. Epub 2020 Oct 29. J Intensive Care Soc. 2022. PMID: 37593542 Free PMC article.
Verification and Validation of Digital Pathology (Whole Slide Imaging) for Primary Histopathological Diagnosis: All Wales Experience.
Babawale M, Gunavardhan A, Walker J, Corfield T, Huey P, Savage A, Bansal A, Atkinson M, Abdelsalam H, Raweily E, Christian A, Evangelou I, Thomas D, Shannon J, Youd E, Brumwell P, Harrison J, Thompson I, Rashid M, Leopold G, Finall A, Roberts S, Housa D, Nedeva P, Davies A, Fletcher D, Aslam M. Babawale M, et al. Among authors: roberts s. J Pathol Inform. 2021 Jan 23;12:4. doi: 10.4103/jpi.jpi_55_20. eCollection 2021. J Pathol Inform. 2021. PMID: 34012708 Free PMC article.
Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.
Poolman M, Roberts J, Wright S, Hendry A, Goulden N, Holmes EA, Byrne A, Perkins P, Hoare Z, Nelson A, Hiscock J, Hughes D, O'Connor J, Foster B, Reymond L, Healy S, Lewis P, Wee B, Johnstone R, Roberts R, Parkinson A, Roberts S, Wilkinson C. Poolman M, et al. Among authors: roberts s, roberts r, roberts j. Health Technol Assess. 2020 May;24(25):1-150. doi: 10.3310/hta24250. Health Technol Assess. 2020. PMID: 32484432 Free PMC article. Clinical Trial.
CARer-ADministration of as-needed subcutaneous medication for breakthrough symptoms in homebased dying patients (CARiAD): study protocol for a UK-based open randomised pilot trial.
Poolman M, Roberts J, Byrne A, Perkins P, Hoare Z, Nelson A, Hiscock J, Hughes D, Foster B, O'Connor J, Reymond L, Healy S, Roberts R, Wee B, Lewis P, Johnstone R, Roberts S, Holmes E, Wright S, Hendry A, Wilkinson C. Poolman M, et al. Among authors: roberts s, roberts r, roberts j. Trials. 2019 Feb 7;20(1):105. doi: 10.1186/s13063-019-3179-9. Trials. 2019. PMID: 30732624 Free PMC article.
Predictive equation derived from 6,497 doubly labelled water measurements enables the detection of erroneous self-reported energy intake.
Bajunaid R, Niu C, Hambly C, Liu Z, Yamada Y, Aleman-Mateo H, Anderson LJ, Arab L, Baddou I, Bandini L, Bedu-Addo K, Blaak EE, Bouten CVC, Brage S, Buchowski MS, Butte NF, Camps SGJA, Casper R, Close GL, Cooper JA, Cooper R, Das SK, Davies PSW, Dabare P, Dugas LR, Eaton S, Ekelund U, Entringer S, Forrester T, Fudge BW, Gillingham M, Goris AH, Gurven M, El Hamdouchi A, Haisma HH, Hoffman D, Hoos MB, Hu S, Joonas N, Joosen AM, Katzmarzyk P, Kimura M, Kraus WE, Kriengsinyos W, Kuriyan R, Kushner RF, Lambert EV, Lanerolle P, Larsson CL, Leonard WR, Lessan N, Löf M, Martin CK, Matsiko E, Medin AC, Morehen JC, Morton JP, Must A, Neuhouser ML, Nicklas TA, Nyström CD, Ojiambo RM, Pietiläinen KH, Pitsiladis YP, Plange-Rhule J, Plasqui G, Prentice RL, Racette SB, Raichlen DA, Ravussin E, Redman LM, Reilly JJ, Reynolds R, Roberts SB, Samaranayakem D, Sardinha LB, Silva AM, Sjödin AM, Stamatiou M, Stice E, Urlacher SS, Van Etten LM, van Mil EGAH, Wilson G, Yanovski JA, Yoshida T, Zhang X, Murphy-Alford AJ, Sinha S, Loechl CU, Luke AH, Pontzer H, Rood J, Sagayama H, Schoeller DA, Westerterp KR, Wong WW, Speakman JR. Bajunaid R, et al. Among authors: roberts sb. Nat Food. 2025 Jan 13. doi: 10.1038/s43016-024-01089-5. Online ahead of print. Nat Food. 2025. PMID: 39806218
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Lancet. 2025 Jan 8:S0140-6736(24)02551-0. doi: 10.1016/S0140-6736(24)02551-0. Online ahead of print. Lancet. 2025. PMID: 39798579
5,972 results